258 related articles for article (PubMed ID: 27222932)
21. Histone deacetylase inhibition is cytotoxic to oligodendrocyte precursor cells in vitro and in vivo.
Dincman TA; Beare JE; Ohri SS; Gallo V; Hetman M; Whittemore SR
Int J Dev Neurosci; 2016 Nov; 54():53-61. PubMed ID: 27587342
[TBL] [Abstract][Full Text] [Related]
22. Effect of a new immunosuppressant histon deacetylase (HDAC) inhibitor FR276457 in a rat cardiac transplant model.
Kinugasa F; Yamada T; Noto T; Matsuoka H; Mori H; Sudo Y; Mutoh S
Biol Pharm Bull; 2008 Sep; 31(9):1723-6. PubMed ID: 18758066
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive effects of an ethyl acetate extract from Urtica dentata Hand on skin allograft rejection.
Xiang M; Hou WR; Xie SN; Zhang WD; Wang X
J Ethnopharmacol; 2009 Oct; 126(1):57-63. PubMed ID: 19698774
[TBL] [Abstract][Full Text] [Related]
24. Impact of interleukin-2-expanded regulatory T cells in various allogeneic combinations on mouse skin graft survival.
Vokaer B; Charbonnier LM; Lemaître PH; Le Moine A
Transplant Proc; 2012 Nov; 44(9):2840-4. PubMed ID: 23146537
[TBL] [Abstract][Full Text] [Related]
25. 5-Aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells.
Hou J; Zhang Q; Fujino M; Cai S; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Xu J; Zou H; Ding Q; Li XK
J Heart Lung Transplant; 2015 Feb; 34(2):254-63. PubMed ID: 25455753
[TBL] [Abstract][Full Text] [Related]
26. Effect of the immunosuppressant histone deacetylase inhibitor FR276457 in a canine renal transplant model.
Kinugasa F; Nagatomi I; Nakanishi T; Noto T; Mori H; Matsuoka H; Sudo Y; Mutoh S
Transpl Immunol; 2009 Sep; 21(4):198-202. PubMed ID: 19409992
[TBL] [Abstract][Full Text] [Related]
27. Tepoxalin, a novel immunomodulatory compound, synergizes with CsA in suppression of graft-versus-host reaction and allogeneic skin graft rejection.
Fung-Leung WP; Pope BL; Chourmouzis E; Panakos JA; Lau CY
Transplantation; 1995 Aug; 60(4):362-8. PubMed ID: 7652766
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade.
Giovannoni L; Muller YD; Lacotte S; Parnaud G; Borot S; Meier RP; Lavallard V; Bédat B; Toso C; Daubeuf B; Elson G; Shang L; Morel P; Kosco-Vilbois M; Bosco D; Berney T
Transplantation; 2015 Jan; 99(1):29-35. PubMed ID: 25340601
[TBL] [Abstract][Full Text] [Related]
29. Induction of regulatory T cells and indefinite survival of fully allogeneic cardiac grafts by ursodeoxycholic acid in mice.
Zhang Q; Nakaki T; Iwami D; Niimi M; Shirasugi N
Transplantation; 2009 Dec; 88(12):1360-70. PubMed ID: 20029332
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase 6 inhibition impairs effector CD8 T-cell functions during skin inflammation.
Tsuji G; Okiyama N; Villarroel VA; Katz SI
J Allergy Clin Immunol; 2015 May; 135(5):1228-39. PubMed ID: 25458911
[TBL] [Abstract][Full Text] [Related]
31. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
32. Astragalus membranaceus injection delayed allograft survival related with CD4+ CD25+ regulatory T cells.
Qu LL; Su YL; Li CX; Hou GH
Transplant Proc; 2010 Nov; 42(9):3793-7. PubMed ID: 21094858
[TBL] [Abstract][Full Text] [Related]
33. Pirfenidone inhibits T-cell activation, proliferation, cytokine and chemokine production, and host alloresponses.
Visner GA; Liu F; Bizargity P; Liu H; Liu K; Yang J; Wang L; Hancock WW
Transplantation; 2009 Aug; 88(3):330-8. PubMed ID: 19667934
[TBL] [Abstract][Full Text] [Related]
34. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, Biological Evaluation, and Computer-Aided Drug Designing of New Derivatives of Hyperactive Suberoylanilide Hydroxamic Acid Histone Deacetylase Inhibitors.
Zhang S; Huang W; Li X; Yang Z; Feng B
Chem Biol Drug Des; 2015 Oct; 86(4):795-804. PubMed ID: 25763653
[TBL] [Abstract][Full Text] [Related]
36. Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans.
Choi SW; Gatza E; Hou G; Sun Y; Whitfield J; Song Y; Oravecz-Wilson K; Tawara I; Dinarello CA; Reddy P
Blood; 2015 Jan; 125(5):815-9. PubMed ID: 25428224
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor beta (TGFβ) plays a crucial role in prolonging allograft survival in an allodepletion ("pruning") skin transplant model.
Watson D; Zhang GY; Hu M; Wang YM; Fletcher J; Sartor M; Alexander SI
Transpl Immunol; 2014 May; 30(4):168-77. PubMed ID: 24746800
[TBL] [Abstract][Full Text] [Related]
38. Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice.
Liang H; Liao C; Qi Z; Sha C; Xie B; Chen J; Xia J; Wang Y; Yao Q; Zhao Y
Transpl Immunol; 2010 Feb; 22(3-4):128-36. PubMed ID: 19755159
[TBL] [Abstract][Full Text] [Related]
39. Histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits anti-inflammatory activities through induction of mitochondrial damage and apoptosis in activated lymphocytes.
Shi ZJ; Ouyang DY; Zhu JS; Xu LH; He XH
Int Immunopharmacol; 2012 Apr; 12(4):580-7. PubMed ID: 22369900
[TBL] [Abstract][Full Text] [Related]
40. LBH589 enhances T cell activation in vivo and accelerates graft-versus-host disease in mice.
Wang D; Iclozan C; Liu C; Xia C; Anasetti C; Yu XZ
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1182-1190.e1. PubMed ID: 22698484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
